Moleculera is a fully-certified and fully-accredited clinical laboratory registered with CLIA (Clinical Laboratory Improvement Amendments) and COLA (Commission on Laboratory Accreditation).
FACEBOOK GUIDELINES:
We are excited to have this platform to engage with parents, patients and professionals who are passionate about helping individuals suffering from infection-induced autoimmune neurologic conditions, such as PANS/PANDAS.
Maintaining privacy for patients and physicians is our top priority. We welcome your comments, suggestions and questions but ask that you not identify physicians by name.
Any postings from the public are not representative of the opinions of Moleculera Labs.
Profanity, vulgarity, ethnic slurs, or disparaging remarks will be removed as will comments that contain advertising, solicitation, spam or fraudulent material.
FACEBOOK GUIDELINES:
We are excited to have this platform to engage with parents, patients and professionals who are passionate about helping individuals suffering from infection-induced autoimmune neurologic conditions, such as PANS/PANDAS.
Maintaining privacy for patients and physicians is our top priority. We welcome your comments, suggestions and questions but ask that you not identify physicians by name.
Any postings from the public are not representative of the opinions of Moleculera Labs.
Profanity, vulgarity, ethnic slurs, or disparaging remarks will be removed as will comments that contain advertising, solicitation, spam or fraudulent material.
Location: United States, Oklahoma, Oklahoma City
Employees: 11-50
Phone: +1 405-239-5250
Total raised: $1.06M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Plains Ven... | plainsvc.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.05.2015 | - | $1.06M | - |
Mentions in press and media 3
| Date | Title | Description |
| 23.05.2024 | Moleculera Biosciences Board of Directors names Healthcare Innovator and Leader Dr. Vijay Aggarwal as Board Chair | Vijay Aggarwal, PhD Moleculera Biosciences Board Chair Dr. Aggarwal's vast life sciences industry experience will help us achieve our vision to change how medicine is practiced for those suffering from immune-mediated CNS and cardiovascular... |
| 11.01.2024 | Moleculera Labs, Inc., Awarded $500,000 Grant Funding to Develop Predictive Treatment Algorithm | Company leveraging strategic alliance w/OKC-based General Genomics to build next-gen predictive treatment model for immune-mediated neuropsychiatric disorders With over 15,000 patient outcomes, we anticipate the ability to predict effective... |
| 20.05.2015 | Moleculera Labs Raises $1.06M in Funding | Moleculera Labs Inc., an Oklahoma City-based developer of tests for autoimmune neurologic conditions in children and adults, raised $1.06m in funding. The round was led by i2E Inc. (which committed $530k through its Accelerate Oklahoma! Fun... |